Loading...
XHELBONEH
Market cap1mUSD
Dec 20, Last price  
0.05EUR
1D
-6.23%
1Q
-84.35%
IPO
-98.90%
Name

BBS-Bioactive Bone Substitutes Oyj

Chart & Performance

D1W1MN
XHEL:BONEH chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
14.95%
Rev. gr., 5y
%
Revenues
0k
00000105,6880000
Net income
-3m
-313,391-626,000-678,000-4,427,000379,8390000-3,483,612
CFO
-3m
L+3.80%
0-430,000-546,000-1,077,000-1,701,000-1,444,000-2,418,000-2,520,000-2,816,000-2,923,000

Profile

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.
URL
https://www.bbs-artebone.fi/
IPO date
Feb 28, 2018
Employees
22
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
Cost of revenue
4
30
57
Unusual Expense (Income)
NOPBT
(4)
(30)
(57)
NOPBT Margin
Operating Taxes
3
141
200
Tax Rate
NOPAT
(4)
(171)
(257)
Net income
(3,484)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
3,830
3,708
BB yield
-64.78%
-31.59%
Debt
Debt current
802
1,133
1,083
Long-term debt
3,951
4,539
5,122
Deferred revenue
176
176
Other long-term liabilities
176
176
176
Net debt
2,782
4,156
4,969
Cash flow
Cash from operating activities
(2,923)
(2,816)
(2,520)
CAPEX
(78)
(125)
Cash from investing activities
(78)
(125)
Cash from financing activities
3,377
3,175
443
FCF
119
(46)
(202)
Balance
Cash
1,971
1,517
1,236
Long term investments
Excess cash
1,971
1,517
1,236
Stockholders' equity
3,713
21,505
17,775
Invested Capital
8,067
8,779
8,956
ROIC
ROCE
EV
Common stock shares outstanding
12,091
9,823
8,459
Price
0.49
-59.08%
1.20
-45.43%
2.19
-53.99%
Market cap
5,913
-49.63%
11,738
-36.64%
18,526
-48.46%
EV
8,695
15,894
23,495
EBITDA
213
195
174
EV/EBITDA
40.75
81.49
134.99
Interest
117
141
200
Interest/NOPBT